pp 1-15 | Cite as

Management of Bradyarrhythmias in Heart Failure: A Tailored Approach

  • Daniele Masarone
  • Ernesto Ammendola
  • Anna Rago
  • Rita Gravino
  • Gemma Salerno
  • Marta Rubino
  • Tommaso Marrazzo
  • Antonio Molino
  • Paolo Calabrò
  • Giuseppe Pacileo
  • Giuseppe Limongelli
Chapter
Part of the Advances in Experimental Medicine and Biology book series

Abstract

Patients with heart failure (HF) may develop a range of bradyarrhythmias including sinus node dysfunction, various degrees of atrioventricular block, and ventricular conduction delay. Device implantation has been recommended in these patients, but the specific etiology should be sought as it may influence the choice of the type of device required (pacemaker vs. implantable cardiac defibrillator). Also, pacing mode must be carefully set in patients with heart failure (HF) and left ventricular systolic dysfunction.

In this chapter, we summarize the knowledge required for a tailored approach to bradyarrhythmias in patients with heart failure.

Keywords

Heart failure reduced ejection fraction Heart failure preserved ejection fraction Bradyarrhytmias Implantable cardioverted defibrillator Pacemaker Cardiomyopathies 

References

  1. Adan V, Crown LA (2003) Diagnosis and treatment of sick sinus syndrome. Am Fam Physician 67:1725–1732Google Scholar
  2. Algalarrondo V, Dinanian S, Juin C et al (2012) Prophylactic pacemaker implantation in familial amyloid polyneuropathy. Heart Rhythm 9:1069–1075Google Scholar
  3. Auricchio A, Salo RW (1997) Acute hemodynamic improvement by pacing in patients with severe congestive heart failure. Pacing Clin Electrophysiol 20:313–319Google Scholar
  4. Bardy GH, Lee KL, Mark DB et al (2005) Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352:225–237Google Scholar
  5. Barold SS, Hayes DL (2001) Second-degree atrioventricular block: a reappraisal. Mayo Clin Proc 76:44–57Google Scholar
  6. Barra SN, Providência R, Paiva L et al (2012) A review on the advanced atrioventricular block in young or middle-aged adults. Pacing Clin Electrophysiol 35:1395–1405Google Scholar
  7. Batra AS, Epstein D, Silka MJ (2003) The clinical course of acquired complete heart block in children with acute myocarditis. Pediatr Cardiol 24:495–497Google Scholar
  8. Bayés de Luna A (2011) Passive arrhythmias, 1st edn. Wiley-Blackwell, OxfordGoogle Scholar
  9. Bharati S, Goldschlager N, Kusumoto F et al (2012) Sinus node dysfunction. In: Camm AJ, Saksena S (eds) Electrophysiological disorders of the heart, 2nd edn. Elsevier Churchill-Livingstone, Philadelphia, pp 207–226Google Scholar
  10. Bindoff L (2003) Mitochondria and the heart. Eur Heart J 24:221–224Google Scholar
  11. Birnie DH, Sauer WH, Bogun F et al (2014) HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm 11:1305–1323Google Scholar
  12. Brignole M (2002) Sick sinus syndrome. Clin Geriatr Med 18:211–227Google Scholar
  13. Brignole M, Auricchio A, Baron-Esquivias G et al (2013) 013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Europace 15:1070–1118Google Scholar
  14. Cattin ME, Muchir A, Bonne G (2013) ‘State-of-the-heart’ of cardiac laminopathies. Curr Opin Cardiol 28:297–304Google Scholar
  15. Choudhury M, Boyett MR, Morris GM (2015) Biology of the sinus node and its disease. Arrhythm Electrophysiol Rev 4:28–34Google Scholar
  16. Cleland JG, Swedberg K, Cohen-Solal A et al (2000) The Euro Heart Failure Survey of the EUROHEART survey program. A survey on the quality of care among patients with heart failure in Europe. The Study Group on Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology. The Medicines Evaluation Group Centre for the Health Economics University of York. Eur J Heart Fail 2:123–132Google Scholar
  17. Dobrzynski H, Boyett MR, Anderson RH (2007) New insights into pacemaker activity: promoting understanding of sick sinus syndrome. Circulation 115:1921–1932Google Scholar
  18. Dresing TJ, Natale A (2001) Congestive heart failure treatment: the pacing approach. Heart Fail Rev 6:15–25Google Scholar
  19. Falk RH (2005) Diagnosis and management of the cardiac amyloidoses. Circulation 112:2047–2060Google Scholar
  20. Finsterer J, Stöllberger C, Keller H (2012) Arrhythmia-related work up in hereditary myopathies. J Electrocardiol 45:376–384Google Scholar
  21. Finsterer J, Stöllberger C, Maeztu C (2016) Sudden cardiac death in neuromuscular disorders. Int J Cardiol 203:508–515Google Scholar
  22. García Ropero Á, Aceña Navarro Á, Farré Muncharaz J (2015) Cardiac amyloidosis and pacemakers: could devices delay diagnosis? Rev Esp Cardiol 68:253–259Google Scholar
  23. Garman SC, Garboczi DN (2004) The molecular defect leading to Fabry disease: structure of human alpha-galactosidase. J Mol Biol 337:319–335Google Scholar
  24. Groh WJ (2012) Arrhythmias in the muscular dystrophies. Heart Rhythm 9:1890–1895Google Scholar
  25. Haines DE, Beheiry S, Akar JG et al (2014) Heart Rythm Society expert consensus statement on electrophysiology laboratory standards: process, protocols, equipment, personnel, and safety. Heart Rhythm 11:19–23Google Scholar
  26. Hamzeh N, Steckman DA, Sauer WH, Judson MA (2015) Pathophysiology and clinical management of cardiac sarcoidosis. Nat Rev Cardiol 12:278–288Google Scholar
  27. Hermans MC, Pinto YM, Merkies IS et al (2010) Hereditary muscular dystrophies and the heart. Neuromuscul Disord 20:479–492Google Scholar
  28. Josephson ME (2008) Sinus node function. In: Clinical cardiac electrophysiology: techniques and interpretations, 4th edn. Lippincott, Williams, & Wilkins, Philadelphia, pp 69–92Google Scholar
  29. Kandolin R, Lehtonen J, Kupari M (2011) Cardiac sarcoidosis and giant cell myocarditis as causes of atrioventricular block in young and middle-aged adults. Circ Arrhythm Electrophysiol 4:303–309Google Scholar
  30. Kim JS, Judson MA, Donnino R (2009) Cardiac sarcoidosis. Am Heart J 157:9–21Google Scholar
  31. Kim JH, Lee BH, Hyang Cho J et al (2016) Long-term enzyme replacement therapy for Fabry disease: efficacy and unmet needs in cardiac and renal outcomes. J Hum Genet 61:923–929Google Scholar
  32. Køber L, Thune JJ, Nielsen JC et al (2016) Defibrillator implantation in patients with nonischemic systolic heart failure. N Engl J Med 375:1221–1230Google Scholar
  33. Kumar S, Barbhaiya C, Nagashima K et al (2015) Ventricular tachycardia in cardiac sarcoidosis: characterization of ventricular substrate and outcomes of catheter ablation. Circ Arrhythm Electrophysiol 8:87–93Google Scholar
  34. Limongelli G, Masarone D, D’Alessandro R, Elliott PM (2012) Mitochondrial diseases and the heart: an overview of molecular basis, diagnosis, treatment and clinical course. Futur Cardiol 8:71–88Google Scholar
  35. Limongelli G, D’Alessandro R, Maddaloni V et al (2013) Skeletal muscle involvement in cardiomyopathies. J Cardiovasc Med 14:837–861Google Scholar
  36. Limongelli G, Masarone D, Pacileo G (2016) Mitochondrial disease and the heart. Heart 1:12–25Google Scholar
  37. Linhart A, Kampmann C, Zamorano JL et al (2007) Cardiac manifestations of Anderson-Fabry disease: results from the international Fabry outcome survey. Eur Heart J 28:1228–1235Google Scholar
  38. Link MS, Berkow LC, Kudenchuk PJ et al (2015) Part 7: adult advanced cardiovascular life support: 2015 American Heart Association guidelines update for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation 132:444–464Google Scholar
  39. Lo R, Menzies DJ, Archer H, Cohen TJ (2003) Complete heart block due to Lyme carditis. J Invasive Cardiol 15:367–369Google Scholar
  40. Lucon A, Palud L, Pavin D et al (2013) Very late effects of dual chamber pacing therapy for obstructive hypertrophic cardiomyopathy. Arch Cardiovasc Dis 106:373–381Google Scholar
  41. Luu M, Stevenson LW, Brunken RC et al (1989) Diverse mechanisms of unexpected cardiac arrest in advanced heart failure. Circulation 80:1675–1680Google Scholar
  42. Mangrum JM, DiMarco JP (2000) The evaluation and management of bradycardia. N Engl J Med 342:703–709Google Scholar
  43. Manios EG, Kanoupakis EM, Mavrakis HE et al (2001) Sinus pacemaker function after cardioversion of chronic atrial fibrillation: is sinus node remodeling related with recurrence? J Cardiovasc Electrophysiol 12:800–806Google Scholar
  44. Masarone D, Limongelli G, Rubino M et al (2017) Management of arrhythmias in heart failure. J Cardiovasc Dev Dis 4:1–20Google Scholar
  45. Mathew V, Olson LJ, Gertz MA et al (1997) Symptomatic conduction system disease in cardiac amyloidosis. Am J Cardiol 80:1491–1492Google Scholar
  46. McVay MR (1984) Atrioventricular block a review. S D J Med 37:21–26Google Scholar
  47. Montaigne D, Pentiah AD (2015) Mitochondrial cardiomyopathy and related arrhythmias. Card Electrophysiol Clin 7:293–301Google Scholar
  48. Morris GM, Kalman JM (2014) Fibrosis, electrics and genetics. Perspectives in sinoatrial node disease. Circ J 78:1272–1282Google Scholar
  49. Moss AJ, Zareba W, Hall WJ et al (2002) Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346:877–883Google Scholar
  50. Mullins CB, Atkins JM (1976) Prognoses and management of ventricular conduction blocks in acute myocardial infarction. Mod Concepts Cardiovasc Dis 45:129–131Google Scholar
  51. Newman LS, Rose CS, Maier LA (1997) Sarcoidosis. N Engl J Med 336:1224–1234Google Scholar
  52. Nicod P, Gilpin E, Dittrich H et al (1988) Long-term outcome in patients with inferior myocardial infarction and complete atrioventricular block. J Am Coll Cardiol 12:589–594Google Scholar
  53. O’Mahony C, Elliott P (2010) Anderson-Fabry disease and the heart. Prog Cardiovasc Dis 52:326–335Google Scholar
  54. O’Mahony C, Coats C, Cardona M et al (2011) Incidence and predictors of anti-bradycardia pacing in patients with the Anderson-Fabry disease. Europace 13:1781–1788Google Scholar
  55. O’Rourke RA (1972) Clinical cardiology: the stokes-Adams syndrome—definition and etiology; mechanisms and treatment. Calif Med 117:96–99Google Scholar
  56. Ponikowski P, Voors AA, Anker SD et al (2016) 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 18:891–975Google Scholar
  57. Priori SG, Blomström-Lundqvist C, Mazzanti A et al (2015) 2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the Task Force for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J 36:2793–2867Google Scholar
  58. Rankin J, Ellard S (2006) The laminopathies: a clinical review. Clin Genet 70:261–274Google Scholar
  59. Rapezzi C, Quarta CC, Riva L et al (2010) Transthyretin-related amyloidoses and the heart: a clinical overview. Nat Rev Cardiol 7:398–408Google Scholar
  60. Rapezzi C, Arbustini E, Caforio AL et al (2013) Diagnostic workup in cardiomyopathies: bridging the gap between clinical phenotypes and final diagnosis. A position statement from the ESC Working Group on Myocardial and Pericardial Diseases. Eur Heart J 34:1448–1458Google Scholar
  61. Rubart M, Zipes DP (2014) Arrhythmias, sudden death, and syncope. In: Libby P, Bonow RO, Mann DL, Zipes D (eds) Braunwald’s heart disease, 10th edn. Saunders Elsevier, Philadelphia, pp 909–921Google Scholar
  62. Schwartzmann D (2014) Atrioventricular block and atrioventricular dissociation. In: Zipes DP, Jalife J (eds) Cardiac electrophysiology: from cell to bedside, 6th edn. Saunders, Philadelphia, pp 485–499Google Scholar
  63. Sinagra G, Anzini M, Pereira NL et al (2016) Myocarditis in clinical practice. Mayo Clin Proc 91:1256–1266Google Scholar
  64. Sneddon JF, Camm AJ (1992) Sinus node disease. Current concepts in diagnosis and therapy. Drugs 44:728–737Google Scholar
  65. Solbiati M, Costantino G, Casazza G et al (2016) Implantable loop recorder versus conventional diagnostic workup for unexplained recurrent syncope. Cochrane Database Syst Rev 4Google Scholar
  66. Stevenson WG, Ellison KE, Sweeney MO et al (2002) Management of arrhythmias in heart failure. Cardiol Rev 10:8–14Google Scholar
  67. Sweeney MO, Prinzen FW (2006) A new paradigm for physiologic ventricular pacing. J Am Coll Cardiol 47:282–290Google Scholar
  68. Sweeney MO, Hellkamp AS, Ellenbogen KA et al (2003) Mode Selection Trial Investigators. The adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation 107:2932–2938Google Scholar
  69. Sylvius N, Tesson F (2006) Lamin A/C and cardiac diseases. Curr Opin Cardiol 21:159–165Google Scholar
  70. Tans C, Lie KI, Durrer D (1980) Clinical setting and prognostic significance of high degree atrioventricular block in acute inferior myocardial infarction: a study of 144 patients. Am Heart J 99:4–8Google Scholar
  71. Tellez JO, Mczewski M, Yanni J et al (2011) Ageing-dependent remodeling of ion channel and Ca2+ clock genes underlying sino-atrial node pacemaking. Exp Physiol 96:1163–1178Google Scholar
  72. Tracy CM, Epstein AE, Darbar D et al (2012) 2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. Circulation 12:1784–1800Google Scholar
  73. Van Rijsingen IA, Arbustini E, Elliott PM et al (2012) Risk factors for malignant ventricular arrhythmias in lamin a/c mutation carriers a European cohort study. J Am Coll Cardiol 59:493–500Google Scholar
  74. Vogler J, Breithardt G, Eckardt L (2012) Bradyarrhythmias and conduction blocks. Rev Esp Cardiol 65:656–667Google Scholar
  75. Waller BF, Gering LE, Branyas NA et al (1993) Anatomy, histology, and pathology of the cardiac conduction system – Part III. Clin Cardiol 16:436–442Google Scholar
  76. Weatherall DJ, Ledingham JGG, Warrell DA (2010) Amyloidosis. In: Warrell DA, Cox TM, Firth JD (eds) Oxford textbook of medicine, 5th edn. University Press, Oxford, pp 1512–1524Google Scholar
  77. Wilkoff BL, Cook JR, Epstein AE et al (2002) Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA 288:3115–3122Google Scholar
  78. Wung SF (2016) Bradyarrhythmias: clinical presentation, diagnosis, and management. Crit Care Nurs Clin North Am 28:297–308Google Scholar
  79. Yilmaz A, Secthem U (2012) Cardiac involvement in muscular dystrophy: advances in diagnosis and therapy. Heart 98:420–428Google Scholar
  80. Zoob M, Smith KS (1963) The etiology of complete heart-block. Br Med J 2:1149–1153Google Scholar

Copyright information

© Springer International Publishing AG 2017

Authors and Affiliations

  • Daniele Masarone
    • 1
  • Ernesto Ammendola
    • 1
  • Anna Rago
    • 1
  • Rita Gravino
    • 1
  • Gemma Salerno
    • 1
  • Marta Rubino
    • 1
  • Tommaso Marrazzo
    • 1
  • Antonio Molino
    • 2
    • 3
  • Paolo Calabrò
    • 4
  • Giuseppe Pacileo
    • 1
  • Giuseppe Limongelli
    • 1
    • 4
    • 5
  1. 1.Cardiomyopathies and Heart Failure Unit-Monaldi HospitalNaplesItaly
  2. 2.First Division of Pneumology Monaldi Hospital-University “Federico II”NaplesItaly
  3. 3.UOC Pneumotisiologia – Department of Clinical Medicine and SurgeryFederico II UniversityNaplesItaly
  4. 4.Department of Cardiothoracic SciencesUniversità della Campania “Luigi Vanvitelli”NaplesItaly
  5. 5.Institute of Cardiovascular Sciences – University College of LondonLondonUK

Personalised recommendations